Friday, 1 February 2013

Cheaper Drugs Forecast for the NHS

AstraZeneca has released its Fourth quarter and full year results for 2012.

Our initial investigation shows decreasing sales, partly driven by the expiry of patents on its best selling drugs. A full copy of the results can be viewed at:

http://www.astrazeneca.com/Media/Press-releases/Article/20130131--astrazeneca-2012-fourth-quarter-and-full-year-results


Whilst this may not be good news for one of the worlds biggest medicine manufacturers, possibly resulting in jobs losses, it is good news for Britain's NHS.

Due the expiry of AstraZeneca patents, the market is opening up for cheaper generic brands to be manufactured; allowing the NHS to purchase medicines at a cheaper price.

So whilst this is not good news for business and investors, it is good news for the NHS.

Posted by at

3 comments:

  1. Unknown1 February 2013 at 16:44

    Drugs aren't always the answer.The NHS should look into alternatives nethods of pain relief such as pet stroking,tickling and distraction.

    ReplyDelete
    Replies
    1. Unknown1 February 2013 at 16:57

      And also 'putting up with it'...

      Delete
    2. scratching my head1 February 2013 at 17:59

      i hate to say it, but Mindfulness training is a good none-medicinal therapy

      Delete

Subscribe to: Post Comments (Atom)